Harry H. Mansbach - 15 Nov 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Medical Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Harry H. Mansbach
Issuer symbol
ETNB
Transactions as of
15 Nov 2022
Net transactions value
-$30,476
Form type
4
Filing time
13 Dec 2022, 16:52:27 UTC
Previous filing
30 Sep 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +9,000 +14% $0.000000 71,951 15 Nov 2022 Direct F1
transaction ETNB Common Stock Tax liability $30,476 -3,113 -4.3% $9.79 68,838 15 Nov 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents settlement by the Issuer of performance-based restricted stock units ("RSUs") granted to the Reporting Person under the Company's Amended and Restated 2019 Equity Incentive Plan on February 17, 2022, which vested based on the Issuer's achievement of department performance objectives.
F2 These shares were withheld from the vesting of a performance-based RSU award to cover the estimated tax withholding obligation.